Among the major questions left unanswered for U.S. importers are how they recoup the money the government collected over the past year.

The vote on February 11 represents an increase in political pressure to change course on Trump’s signature economic policy just months before the midterm elections.

Integrated automation solutions deliver significant benefits to pharma companies onshoring manufacturing capacity.

GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both food and pharma supply chains.

The deal between the U.S. and European Union on trade in pharmaceutical products promises to have a deep impact on the underlying structure of the industry.

Management of healthcare shipments requires not only logistics expertise but also a deep understanding of regulatory frameworks.

Beyond hunkering down in firefighting mode, it’s just as important that companies take a longer view of things.

The U.S. economy appears to be in decent shape – but there could be some dark clouds massing on the horizon.

Companies seeking to navigate uncertainties arising from the U.S-China trade relationship can take a proactive posture to enhance the competitiveness of domestic production.

Retailer support for 2D barcodes, such as QR codes, is improving, but not yet universal. Logistics leaders need to act before 2027.